科研製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/06/07 | 3,824 | 3,842 | 3,806 | 3,823 | -20 | -0.5% | 171,200 |
| 2024/06/06 | 3,925 | 3,985 | 3,821 | 3,843 | -12 | -0.3% | 363,000 |
| 2024/06/05 | 3,722 | 3,855 | 3,693 | 3,855 | +94 | +2.5% | 455,000 |
| 2024/06/04 | 3,788 | 3,827 | 3,636 | 3,761 | -27 | -0.7% | 555,500 |
| 2024/06/03 | 3,667 | 3,874 | 3,646 | 3,788 | +213 | +6% | 662,700 |
| 2024/05/31 | 3,662 | 3,674 | 3,534 | 3,575 | -91 | -2.5% | 401,200 |
| 2024/05/30 | 3,590 | 3,680 | 3,570 | 3,666 | +47 | +1.3% | 385,700 |
| 2024/05/29 | 3,584 | 3,645 | 3,540 | 3,619 | +175 | +5.1% | 427,500 |
| 2024/05/28 | 3,460 | 3,463 | 3,444 | 3,444 | -24 | -0.7% | 87,800 |
| 2024/05/27 | 3,452 | 3,468 | 3,441 | 3,468 | +6 | +0.2% | 85,300 |
| 2024/05/24 | 3,438 | 3,462 | 3,431 | 3,462 | +24 | +0.7% | 73,100 |
| 2024/05/23 | 3,415 | 3,450 | 3,406 | 3,438 | +30 | +0.9% | 70,800 |
| 2024/05/22 | 3,427 | 3,431 | 3,407 | 3,408 | -28 | -0.8% | 89,000 |
| 2024/05/21 | 3,439 | 3,481 | 3,436 | 3,436 | -4 | -0.1% | 127,000 |
| 2024/05/20 | 3,439 | 3,455 | 3,416 | 3,440 | -11 | -0.3% | 102,000 |
| 2024/05/17 | 3,426 | 3,455 | 3,416 | 3,451 | +8 | +0.2% | 115,300 |
| 2024/05/16 | 3,383 | 3,443 | 3,378 | 3,443 | +61 | +1.8% | 119,000 |
| 2024/05/15 | 3,473 | 3,473 | 3,378 | 3,382 | -101 | -2.9% | 249,800 |
| 2024/05/14 | 3,535 | 3,560 | 3,449 | 3,483 | -65 | -1.8% | 358,200 |
| 2024/05/13 | 3,520 | 3,560 | 3,506 | 3,548 | +28 | +0.8% | 179,000 |
| 2024/05/10 | 3,497 | 3,520 | 3,478 | 3,520 | +37 | +1.1% | 170,600 |
| 2024/05/09 | 3,478 | 3,499 | 3,464 | 3,483 | +4 | +0.1% | 177,900 |
| 2024/05/08 | 3,466 | 3,487 | 3,456 | 3,479 | +11 | +0.3% | 113,600 |
| 2024/05/07 | 3,470 | 3,481 | 3,456 | 3,468 | -10 | -0.3% | 128,300 |
| 2024/05/02 | 3,481 | 3,485 | 3,463 | 3,478 | +1 | ±0% | 108,100 |
| 2024/05/01 | 3,425 | 3,488 | 3,409 | 3,477 | +52 | +1.5% | 128,400 |
| 2024/04/30 | 3,425 | 3,442 | 3,399 | 3,425 | +18 | +0.5% | 202,200 |
| 2024/04/26 | 3,387 | 3,416 | 3,367 | 3,407 | +18 | +0.5% | 132,500 |
| 2024/04/25 | 3,411 | 3,416 | 3,389 | 3,389 | -29 | -0.8% | 120,000 |
| 2024/04/24 | 3,435 | 3,446 | 3,414 | 3,418 | -21 | -0.6% | 149,100 |
| 2024/04/23 | 3,456 | 3,458 | 3,421 | 3,439 | -19 | -0.5% | 94,300 |
| 2024/04/22 | 3,436 | 3,464 | 3,426 | 3,458 | +44 | +1.3% | 125,500 |
| 2024/04/19 | 3,423 | 3,423 | 3,394 | 3,414 | -9 | -0.3% | 90,200 |
| 2024/04/18 | 3,389 | 3,433 | 3,389 | 3,423 | +35 | +1% | 69,700 |
| 2024/04/17 | 3,417 | 3,417 | 3,375 | 3,388 | -36 | -1.1% | 99,400 |
| 2024/04/16 | 3,416 | 3,436 | 3,412 | 3,424 | -4 | -0.1% | 98,000 |
| 2024/04/15 | 3,423 | 3,436 | 3,416 | 3,428 | -10 | -0.3% | 71,100 |
| 2024/04/12 | 3,420 | 3,438 | 3,415 | 3,438 | +20 | +0.6% | 73,200 |
| 2024/04/11 | 3,418 | 3,430 | 3,403 | 3,418 | -7 | -0.2% | 87,200 |
| 2024/04/10 | 3,426 | 3,446 | 3,425 | 3,425 | +5 | +0.1% | 82,400 |
| 2024/04/09 | 3,441 | 3,446 | 3,411 | 3,420 | -22 | -0.6% | 119,200 |
| 2024/04/08 | 3,440 | 3,446 | 3,422 | 3,442 | -3 | -0.1% | 107,500 |
| 2024/04/05 | 3,415 | 3,450 | 3,415 | 3,445 | +30 | +0.9% | 74,900 |
| 2024/04/04 | 3,423 | 3,428 | 3,414 | 3,415 | -8 | -0.2% | 108,800 |
| 2024/04/03 | 3,419 | 3,444 | 3,405 | 3,423 | +4 | +0.1% | 151,300 |
| 2024/04/02 | 3,457 | 3,457 | 3,416 | 3,419 | -48 | -1.4% | 175,500 |
| 2024/04/01 | 3,460 | 3,475 | 3,455 | 3,467 | +8 | +0.2% | 87,800 |
| 2024/03/29 | 3,417 | 3,465 | 3,417 | 3,459 | +43 | +1.3% | 98,100 |
| 2024/03/28 | 3,508 | 3,508 | 3,416 | 3,416 | -170 | -4.7% | 379,600 |
| 2024/03/27 | 3,607 | 3,621 | 3,586 | 3,586 | -9 | -0.3% | 222,500 |
251～
300
件表示中 / 3722件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 科研薬 | 386,600円 | -6.4% | -71.8% | 4.91% | 43.06倍 | 0.96倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| ジーエヌアイ | 387,000円 | +21.7% | +999.9% | 0.00% | 16.22倍 | 5.36倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 鳥居薬 | 636,000円 | +7.1% | -35.0% | 0.00% | 52.59倍 | 1.47倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| 東和薬品 | 299,200円 | +7.9% | -3.3% | 2.67% | 8.32倍 | 0.86倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| ゼリア新薬 | 203,900円 | +3.1% | -6.5% | 2.35% | 9.46倍 | 1.00倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム
